|
|
Prescribing Opioids for Chronic Pain
Jointly Sponsored by Indiana Society of Addiction Medicine and the American Society of Addiction Medicine
With support from Center for Substance Abuse Treatment, SAMHSA and Fairbanks
Do you prescribe opioid medications? If so, this program is for you.
Each year, millions of patients are treated for a variety of serious medical conditions with prescription drugs whose therapeutic benefits are accompanied by psychoactive effects. Recent indicators reveal that the misuse and abuse of prescription drugs are rising, and we are faced with the challenge of minimizing the potential for misuse without impeding patients' access to needed medical care. This symposium will provide specific knowledge and skills associated with safe prescribing and will cover areas of epidemiology, legal and regulatory issues, as well as clinical strategies for managing difficult patient situations.
| WHEN |
Friday, June 27 |
| TIME |
8:30 am to 4:00 pm |
| WHERE |
Fairbanks
8102 Clearvista Parkway
Indianapolis, IN 46256 |
Educational Objectives
Define risk factors for potential misuse or abuse of prescription medications, and outline a time efficient method of screening for risk.
Select patients who are appropriate candidates for pain therapy with opioids, including methadone.
Educate patients about methadone's unique pharmacologic properties, such as its long duration of action and absence of euphoric effect (because lack of knowledge of these characteristics on the part of physicians and patients has contributed to inadvertent overdoses and fatalities).
Follow a careful, evidence-based protocol for starting patients on opioid analgesic therapy, including methadone, whether from a drug-naive state or in transition from another short- or long-acting opioid analgesic.
Take appropriate steps to monitor for effectiveness of the medications and to minimize the potential for diversion, abuse, or addiction.
Who Should Attend
This program is designed for physicians in primary care and nurse practitioners.
Faculty
Theodore V. Parran, MD, MPH
Associate Clinical Professor, Associate Clinical Director, Departments of Medicine and Family Medicine, Case Western Reserve School of Medicine, Cleveland, Ohio
John A. Hopper, MD
Chief Medical Officer, Brighton Hospital; Clinical Associate Professor, Departments of Internal Medicine, Pediatrics, Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan
Tina Baxter, MSN, NP
Nurse Educator at Fairbanks, Indianapolis, Indiana
Agenda
| 8:00 am |
Registration |
| 8:30 |
Introduction to the Course |
| 8:50 |
First Things First: Whether to Prescribe an Opioid |
| 10:00 |
General Pharmacologic Principles About All Opioids |
| 10:45 |
Break |
| 11:00 |
Case Illustrations |
| 12:00 pm |
Break for Lunch (on your own) |
| 1:00 |
Using Pearls to Avoid Pitfalls |
| 1:40 |
The Role of NPs When the Patient is Receiving Opioids for Chronic Pain |
| 2:00 |
Case Illustrations |
| 2:30 |
Break |
| 2:40 |
When, Why and How to Stop Prescribing Controlled Substances |
| 3:10 |
Case Illustrations |
| 4:00 |
Adjournment |
Fees
The cost for this program is $45 for registrations received by June 1; $50 after June 1
Lodging
The hotel closest to Fairbanks is the Hilton Indianapolis North Hotel, 8181 North Shadeland Avenue, Indianapolis, IN 46250. 317-849-6668.
Continuing Medical Education Credits
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society of Addiction Medicine (ASAM) and the Indiana Chapter of ASAM (INSAM). The American Society of Addiction Medicine designates this educational activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure
As a provider accredited by ACCME, ASAM must ensure balance, independence, objectivity, and scientific rigor in its educational activities. All faculty participating in an ASAM activity are required to disclose commitments to and/or relationships with pharmaceutical companies, biomedical device manufacturers or distributors, or others whose products or services may be considered to be related to the subject matter of the educational activity. For this program, Dr. Parran has indicated that he has no significant interests to disclose. Dr. Hopper reported that he has received honoraria from Reckitt Benckiser Pharmaceuticals.
QUESTIONS?
Contact Susan Day at 317-572-9401 or at sday@fairbankscd.org
|
|
